Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC-Gender-II: Acute Effects of THC in Healthy Humans
NCT04704271Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Oct 2019
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of dronabinol (2 arms), sponsored by Yale University. Primary endpoints: Visual Analog Scale for Rewarding Effects at 300 months and Rey Auditory Verbal Learning Test at 80 months. Started Oct 2019; status: recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT04704271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04704271.